Epirubicin Hydrochloride 50 mg Lyophilized Powder for IV Injection
Indication
Epirubicin Hydrochloride has produced responses in a wide range of neoplastic conditions including breast, ovarian, gastric, lung and colorectal carcinomas, malignant lymphomas, leukemias and multiple myeloma.
You are now entering the prescription medicines section of this website. This page is intended exclusively for healthcare professionals and patients who have been prescribed the relevant medication. By continuing, you confirm that you meet this criteria.
Please consult your physician or other qualified healthcare providers before taking any prescription medicines mentioned here. The information provided is for educational and informational purposes only and should not be considered a substitute for professional medical advice. Always read the product packaging and labels carefully before use.
